Invention Grant
US08173708B2 Method and composition for administering an NMDA receptor antagonist to a subject
有权
用于给受试者施用NMDA受体拮抗剂的方法和组合物
- Patent Title: Method and composition for administering an NMDA receptor antagonist to a subject
- Patent Title (中): 用于给受试者施用NMDA受体拮抗剂的方法和组合物
-
Application No.: US12757819Application Date: 2010-04-09
-
Publication No.: US08173708B2Publication Date: 2012-05-08
- Inventor: Gregory T. Went , Timothy J. Fultz , Laurence R. Meyerson
- Applicant: Gregory T. Went , Timothy J. Fultz , Laurence R. Meyerson
- Applicant Address: US CA Emeryville
- Assignee: Adamas Pharmaceuticals, Inc.
- Current Assignee: Adamas Pharmaceuticals, Inc.
- Current Assignee Address: US CA Emeryville
- Agency: Wilson, Sonsini, Goodrich & Rosati
- Main IPC: A01N47/28
- IPC: A01N47/28 ; A01N31/15 ; A61K31/17 ; A61K27/00 ; A61K9/00
Abstract:
The invention provides methods and compositions for administering an NMDA receptor antagonist (e.g., memantine) to a subject.
Public/Granted literature
- US20120058182A9 METHOD AND COMPOSITION FOR ADMINISTERING AN NMDA RECEPTOR ANTAGONIST TO A SUBJECT Public/Granted day:2012-03-08
Information query
IPC分类:
